Paul Industries delivers validation and commissioning in Pennsylvania for pharmaceutical, vaccine, biologics and cell therapy plants, writing and executing commissioning, IQ, OQ and PQ protocols for process equipment, utilities and clean rooms and turning over a package the plant’s quality unit can approve. Pennsylvania is adding new drug manufacturing capacity measured in billions of dollars, with plants under way in the Lehigh Valley, Montgomery County and Lancaster County. Every one of those systems has to be commissioned and qualified before it makes product for patients.

Request a quote or call 201-450-8280

Headquarters 256 Shore Drive, Kilmarnock, Virginia
Lehigh Valley Lilly's $3.5 billion Fogelsville plant, operational 2031 (announced January 2026)
Montgomery County Merck's $2.9 billion vaccine, medicine and research expansion through 2030
Pressure vessels Field-inspected every three years under state law; certificate posted at the vessel
FDA inspections Risk-based schedule since FDASIA (2012)
Reviewed November 2026

What is CQV, and how does it run on Pennsylvania projects?

CQV is commissioning, qualification and validation: the engineering and quality work that proves a new or modified manufacturing system was built as designed, works as intended and consistently produces the quality the process needs. Commissioning is the engineering half, covering inspection, startup, adjustment and functional testing. Qualification is the regulated half, documenting in IQ, OQ and PQ protocols that the critical aspects of the system meet their acceptance criteria. Validation, in the strict sense, is the manufacturer’s process validation that follows on qualified equipment.

On CQV pharma projects in Pennsylvania, the CQV process is usually built on ASTM E2500 and the second edition of the ISPE commissioning and qualification guide, which ask the team to identify critical aspects through risk assessment, test them once with good engineering practice, and let qualification lean on that commissioning evidence instead of repeating it. CQV in pharma plants also has to satisfy 21 CFR Parts 210 and 211 in the United States and, for plants that export, EU GMP Annex 15 and the revised Annex 1. The national validation and commissioning page sets out protocol content and definitions; this page deals with how that work plays out at Pennsylvania plants.

Pennsylvania’s new drug manufacturing capacity through 2031

Pennsylvania’s new drug manufacturing capacity through 2031 is led by a handful of very large projects announced since late 2024, each of which will need commissioning and qualification of its utilities, equipment, clean rooms and automation before release. The figures below come from the companies’ and the Commonwealth’s announcements and are listed as market facts.

Announced pharmaceutical and biologics manufacturing investments in Pennsylvania
Company and siteAnnouncedScopeStated timing
Eli Lilly, Fogelsville, Upper Macungie Township (Lehigh Valley)January 2026, $3.5 billionInjectable medicine and device manufacturing, about 850 jobsConstruction from later in 2026; operational in 2031
Merck, West Point and Montgomery CountyOctober 2026, $2.9 billionVaccine and medicine manufacturing and research, including a $550 million facility at West PointThrough the end of 2030
GSK, Upper Merion TownshipOctober 2026, more than $800 millionCommercial-scale biologics plant, pilot plant, quality control laboratoryConstruction expected to begin in 2027
GSK, Marietta (Lancaster County)October 2024, up to $800 millionDrug substance and sterile liquid drug product capacityDrug substance by 2027; drug product by 2028

Programs of that size run commissioning and qualification in parallel with construction, so the validation master plan, the risk assessments, the protocol templates and the turnover system have to be in place well before mechanical completion. They also pull suppliers, utility upgrades and smaller plant expansions into the same regions, which is where most of the day-to-day qualification work in Pennsylvania sits: a new purified water loop, a replacement autoclave, a clean room retrofit or a new filling line inside an operating plant.

Where does validation and commissioning in Pennsylvania happen?

Validation and commissioning in Pennsylvania is concentrated in the southeastern counties around Philadelphia, with growing work in the Lehigh Valley, Berks and Lancaster counties, the Harrisburg area and Pittsburgh. Each region has its own mix of large manufacturing campuses, contract manufacturers, clinical-stage developers and research institutions.

Montgomery and Chester counties

West Point, Upper Merion, King of Prussia, Collegeville, Malvern and Exton hold vaccine, biologics, small-molecule and contract manufacturing sites, many of them operating campuses where new systems must be qualified next to running production. Change control, shared utility tie-ins and requalification of existing systems are as common there as greenfield protocols.

Philadelphia’s cell and gene therapy cluster

Philadelphia’s cell and gene therapy cluster grew from research at the University of Pennsylvania and Children’s Hospital of Philadelphia, which contributed to two landmark FDA approvals in 2017: Kymriah, a CAR-T cell therapy approved in August, and Luxturna, the first gene therapy approved in the United States for an inherited disease, in December. Clinical and commercial manufacturing suites in University City, the Navy Yard and the suburbs now qualify closed processing equipment, biosafety cabinets, controlled-rate freezers, incubators and clean rooms on short, phase-appropriate timelines.

Lehigh Valley, Berks and Lancaster counties

The Lehigh Valley around Allentown and Bethlehem, Reading and Berks County, and Lancaster County hold pharmaceutical, medical device, vaccine packaging and nutraceutical plants, with the Fogelsville and Marietta projects adding new capacity. Qualification work there ranges from sterile drug product lines to packaging, warehouse temperature mapping and utility systems.

Harrisburg, State College and Pittsburgh

Central Pennsylvania adds contract manufacturers and consumer health plants, and the Pittsburgh region adds biologics developers, university research facilities and medical manufacturing. Projects there are often smaller single-system programs that need a complete qualification package without a large validation department behind them.

CQV services from design review to release

CQV services from design review to release follow a fixed sequence on Pennsylvania projects, starting with the user requirements and the risk assessment and ending with a summary report that releases the system for process validation or routine use. The table shows the CQV activities at each phase and who signs them.

CQV activities by project phase on a Pennsylvania pharmaceutical project
PhaseCommissioning activitiesQualification activitiesApproved by
PlanningCommissioning plan, system boundaries, turnover structureValidation master plan, user requirements, system impact and criticality assessmentsProject engineering and the quality unit
DesignDesign reviews, vendor document requirementsDesign qualification or design review against requirements and risk controlsEngineering, quality
FabricationFactory acceptance tests, vendor turnover packagesDecision on which factory tests are leveraged into qualificationEngineering, with quality review
InstallationWalkdowns, punch lists, weld and material records, loop checksInstallation qualification of critical aspectsEngineering; IQ approved by quality
StartupSite acceptance tests, functional tests, tuning, alarmsOperational qualification of critical functionsEngineering; OQ approved by quality
PerformanceOperator training, handover to maintenancePerformance qualification under routine conditions; summary report and releaseQuality unit

Under this model the same test is never run twice for two audiences. A commissioning functional test executed under good documentation practice, with calibrated instruments and approved procedures, can be referenced directly in the OQ, and a vendor’s factory acceptance test can count where the risk assessment says so and the quality unit agrees in advance. Paul Industries writes the plan with that leverage built in, so a Pennsylvania plant gets one CQV validation package rather than two parallel sets of paper. The older sequence of separate commissioning, qualification, verification steps still appears in some site procedures, and the plan maps each of those steps onto the risk-based program so nothing the procedure requires is lost.

Commissioning and qualification for biologics, vaccine and cell therapy suites

Commissioning and qualification for biologics, vaccine and cell therapy suites in Pennsylvania centers on the systems that protect the product: clean rooms and their air handling, water for injection and clean steam, bioreactors and single-use assemblies, autoclaves and parts washers, and the monitoring systems that record all of it. The revised EU GMP Annex 1, in force since August 2023, has pushed sterile and aseptic plants toward a documented contamination control strategy, and qualification protocols now trace their tests back to that strategy.

Cell therapy suites bring their own items. Closed processing reduces the clean room grade a step needs, but only if the closure itself is qualified; controlled-rate freezers and liquid nitrogen storage need temperature mapping across the load; and biosafety cabinets and isolators need airflow and integrity testing before aseptic work. Vaccine and biologics plants add viral clearance segregation, pressure cascades between suites and decontamination cycles. Paul Industries qualifies those systems and the clean rooms in Pennsylvania that house them, along with cleaning and inactivation systems that serve the suites.

Utility qualification: water, clean steam, gases and air handling

Utility qualification at Pennsylvania plants covers the systems that touch product or product-contact surfaces: purified water and water for injection, pure steam, process gases and compressed air, and the HVAC that holds clean room classification. Each has its own compendial or consensus limits, and each runs a performance qualification long enough to show seasonal variation, which matters in a state with humid summers and cold winters that load air handlers and cooling systems very differently through the year.

Utility qualification tests and acceptance bases
SystemKey OQ testsPQ approachAcceptance basis
Purified waterFlow and velocity in the loop, alarms, sanitization cycle, sample valve functionThree phases: two to four weeks of intensive sampling, two to four weeks more, then one year of routine dataUSP conductivity and TOC limits; microbial action level 100 CFU/mL under USP general chapter 1231
Water for injectionStill or membrane performance, hot loop temperature, alarmsSame three phases, with endotoxin testingUSP limits; endotoxin 0.25 EU/mL; microbial action level 10 CFU/100 mL
Pure steamGenerator performance, distribution drainage, trap functionCondensate sampling at use pointsWFI quality condensate; non-condensable gas, dryness and superheat where specified
Compressed air and process gasesPressure, dew point, filtration, alarm checksSampling at points of use over a defined periodISO 8573-1 purity classes set by the user requirements; viable and nonviable counts
Clean room HVACAirflow, HEPA integrity, pressure cascade, recoveryEnvironmental monitoring in operation over the qualification periodISO 14644-1 class; EU Annex 1 grade limits for sterile plants

Water systems are where Pennsylvania plants most often ask for help after something has gone wrong, a drifting conductivity trend or a microbial excursion during phase 1. Paul Industries investigates the system as well as the data, because the cause is often physical: a dead leg, a sample valve that does not drain, a heat exchanger with a pinhole or a loop velocity that dropped when a new branch was added. The high-purity water systems in Pennsylvania page covers the build side of those loops, and passivation before qualification is covered on the passivation in Pennsylvania page.

Which Pennsylvania state records belong in an autoclave or vessel IQ?

Pennsylvania state records belong in the IQ of any autoclave, pressure vessel, jacketed tank or pure steam generator that falls under the Boiler and Unfired Pressure Vessel Law, because the qualified system is only fit for use while it holds a valid certificate of operation. Under 34 Pa. Code Chapter 3a, the Department of Labor and Industry issues that certificate after an inspection shows the unit is safe at its stated pressure, and the certificate is posted as close as possible to the vessel. Unfired pressure vessels are field-inspected every three years.

The IQ should capture the ASME data report and nameplate, the National Board registration, the relief device set pressures and capacities, the certificate of operation and the date of the next state inspection. A repair or alteration that affects working pressure or safety requires the owner to consult an inspector first, so the change control for any qualified vessel needs a step that checks whether the state must be involved. Paul Industries installs and qualifies autoclaves through its autoclave installation work, with thermal mapping, chamber leak testing, air removal tests and load studies in the OQ and PQ.

Process equipment qualification: bioreactors, filling lines, washers and skids

Process equipment qualification at Pennsylvania plants covers the systems that make, hold, clean and fill the product: bioreactors and fermenters, media and buffer preparation skids, chromatography and filtration skids, formulation vessels, parts and glassware washers, filling and stoppering lines, and lyophilizers. Each one carries vendor testing, utility connections and automation, so its qualification is as much about interfaces as about the equipment itself.

A bioreactor IQ, for example, verifies the vessel, its jacket and instruments, the gas and feed lines, the steam and condensate connections and the control system configuration; the OQ tests temperature, pH, dissolved oxygen and agitation control, sterilization in place and alarm responses; and the PQ, often a media run, shows the system holds sterility and control through a full cycle. Filling lines add weight checks, stopper and capping performance, and the barrier or isolator around them. Washers need spray coverage and cleaning cycle tests that support the plant’s cleaning validation. Paul Industries sets up and qualifies that equipment, including systems from its bioreactor installation work, and coordinates factory testing so vendor data counts toward the protocols wherever the risk assessment allows.

Cleaning, sterilization and decontamination cycle qualification

Cleaning, sterilization and decontamination cycles are qualified as equipment functions before the plant runs its own cleaning validation, and at Pennsylvania biologics and vaccine plants they are often the longest part of an OQ. A clean-in-place circuit is first shown to wet every product-contact surface, typically with a riboflavin coverage test under ultraviolet light, and then to deliver the flows, temperatures, concentrations and times its cycle specifies at every path.

Steam-in-place cycles are qualified by placing thermocouples at the cold points of each vessel and line, such as drain valves, filter housings and long branches, and showing that every point reaches and holds sterilizing temperature, with biological indicators where the protocol calls for them. Vaporized hydrogen peroxide cycles for isolators, pass-throughs and rooms are developed and then challenged with chemical and biological indicators at the hardest-to-reach locations, with aeration time confirmed so residual levels are safe for people and product. Paul Industries develops those cycles with the equipment vendor’s settings as a starting point, records the final parameters in the protocol and hands the plant a cycle that its operators can repeat and its quality unit can defend.

Automation, data integrity and computerized systems

Automation and computerized systems are qualified alongside the equipment they run, because a Pennsylvania plant’s batch records, alarms and environmental data now live in control systems, historians and monitoring software rather than on paper. The work follows GAMP 5, scaled to the risk of each function, and 21 CFR Part 11 for electronic records and signatures.

Testing covers configuration against the approved specification, recipes and sequences, interlocks and alarms, user roles and passwords, audit trails, time synchronization, data transfer to historians and backup and restore. Monitoring systems for clean rooms, cold rooms and incubators get their sensors calibrated and mapped, their alarm delays justified, and their records checked for completeness. Paul Industries tests those functions with the plant’s automation and quality staff and records the results in the same traceability matrix as the mechanical tests, so the summary report covers the whole system.

Change control when a qualified Pennsylvania system is modified

Change control decides how much qualification a modification needs, and at Pennsylvania plants with years of qualified systems behind them, most CQV work is changes rather than new builds. A risk assessment compares the change against the system’s critical aspects: a new branch on a water loop affects velocity, temperature and drainability; a control system upgrade affects alarms, recipes and data; a replaced pump of the same model may need little more than an IQ addendum and a functional check.

The result is a targeted protocol that tests what the change could affect and references the rest of the original qualification, followed by a periodic review that confirms the system is still in its qualified state. Paul Industries writes the impact assessment, executes the targeted testing, updates the drawings and system descriptions, and folds the change into the next periodic review. Scheduled requalification of autoclaves, clean rooms, water systems and temperature-controlled units is covered on the annual requalification page.

What does a CQV program cost for a Pennsylvania plant?

The cost of a CQV program for a Pennsylvania plant is driven by the number of systems, how many are direct-impact, the depth of automation and data integrity testing, whether vendor testing can be leveraged, the length of each performance qualification, and how much of the work must fit around running production. A single direct-impact utility with a vendor package that supports leverage is a small program; a new sterile filling facility with dozens of systems, a building management and monitoring system and a year of water data is a large one.

Protocol writing, execution, deviation handling and the summary report are the main labor lines, and test equipment such as thermal mapping systems, particle counters and calibrated reference instruments adds to them. Paul Industries prices CQV from the system list and the validation master plan, or from the user requirements where no plan exists yet, with a budget range by system first and a firm price once protocol scope and leverage are agreed with the quality unit.

Who performs validation and commissioning in Pennsylvania?

Paul Industries performs validation and commissioning in Pennsylvania. Based first in northern New Jersey and then in Pennsylvania, the company now has its headquarters at 256 Shore Drive in Kilmarnock, Virginia, and works as an East Coast contractor. It writes and executes commissioning plans and IQ, OQ and PQ protocols for plants in Philadelphia, the Montgomery and Chester county corridor, the Lehigh Valley, Reading, Lancaster, Harrisburg and Pittsburgh, and qualifies systems in every one of the 50 states and for overseas plants, described on its international page.

Plants use Paul Industries in three ways: to execute protocols the plant’s own quality group has written, to write and execute the full program, or as part of a design-build contract in which Paul Industries designs, fabricates, installs, commissions and qualifies the system, so the person who built the loop also proves it. The validation and commissioning in Virginia page describes the same service in the headquarters state, and the validation and commissioning in New Jersey page covers the state next door. Process lines that feed qualified systems are built under the process piping in Pennsylvania service.

Validation and commissioning from Paul Industries across Pennsylvania

Paul Industries commissions and qualifies process equipment, utilities, clean rooms, autoclaves and automated systems for pharmaceutical, vaccine, biologics and cell therapy plants across Pennsylvania, and requalifies systems already in service. Send the system list, the user requirements or validation master plan, the vendor documents available and the target release date, and Paul Industries will set out the protocols, schedule and cost. Call 201-450-8280 or request a quote. All of the company’s work in the state is summarized on the Pennsylvania page.

Standards referenced: ASTM E2500 · ISPE Baseline Guide Volume 5: Commissioning and Qualification · GAMP 5 · 21 CFR Parts 210 and 211 · 21 CFR Part 11 · EU GMP Annex 1 · EU GMP Annex 15 · USP <1231>, <645>, <643>, <85> · ISO 14644-1 · ISO 8573-1 · Pennsylvania Boiler and Unfired Pressure Vessel Law; 34 Pa. Code ch. 3a · Pennsylvania Uniform Construction Code

Frequently asked questions

Who qualifies new systems at pharmaceutical and vaccine plants in Montgomery County?

Paul Industries qualifies new utilities, process equipment, clean rooms and autoclaves at pharmaceutical, vaccine and biologics plants in West Point, Upper Merion, King of Prussia, Collegeville and the rest of Montgomery County, as well as Malvern and Exton in Chester County. Much of that work happens inside operating campuses, so protocols are scheduled around production and change control ties each new system into the existing qualified state.

Does Paul Industries commission and qualify cell therapy suites in Philadelphia?

Yes. Paul Industries commissions and qualifies clean rooms, biosafety cabinets, incubators, controlled-rate freezers, liquid nitrogen storage and closed processing equipment for cell and gene therapy suites in Philadelphia, University City and the Navy Yard. Clinical-stage suites usually get phase-appropriate protocols that grow into full commercial qualification as the product advances, with the same documents extended rather than rewritten.

Who performs commissioning and qualification for plants in the Lehigh Valley and Lancaster County?

Paul Industries performs commissioning and qualification for pharmaceutical, medical device, vaccine packaging and nutraceutical plants in Allentown, Bethlehem, Fogelsville, Reading, Lancaster and Marietta. Work there ranges from sterile drug product lines and utilities to warehouse and cold room temperature mapping, and Paul Industries delivers it as single-system packages or as part of a larger program.

What are CQV services, and what does a plant receive at the end?

CQV services are the planning, protocol writing, test execution, deviation handling and reporting that take a new or modified GMP system from installation to release. At the end the plant receives approved commissioning records, executed IQ, OQ and PQ protocols with raw data, a deviation log with closures, a traceability matrix back to the user requirements and a summary report that releases the system.

Does a Pennsylvania plant need a CQV consultant as well as a contractor?

Paul Industries covers both roles. It writes the validation master plan, risk assessments and protocols expected of a CQV consultant, and it executes them on the systems it installs and on systems from any other builder. Keeping planning and execution together means the tests in the protocol match the equipment as built and deviations are resolved by the people who know the installation.

What is commissioning and qualification under a science- and risk-based approach?

Under ASTM E2500 and the ISPE guide, commissioning and qualification form one program. Risk assessment identifies the critical aspects of a system, commissioning tests the whole system with good engineering practice, and qualification documents that the critical aspects meet their acceptance criteria, using commissioning evidence wherever it is suitable. Subject matter experts design the tests and the quality unit approves what is relied on.

What is commissioning in pharmaceutical industry practice, and where does it stop?

Commissioning is the engineering process of inspecting, starting up, adjusting and functionally testing a system so it runs as designed. It stops at the point where the quality unit needs documented evidence that critical aspects meet acceptance criteria; that evidence is qualification. In a well-run program, commissioning tests executed under good documentation practice are carried directly into the qualification record.

What pharmaceutical companies are in Pennsylvania, and which are building new plants?

Pennsylvania pharmaceutical companies range from Merck at West Point and GSK at Upper Merion and Marietta to Eli Lilly, whose $3.5 billion Fogelsville plant was announced in January 2026, along with many contract manufacturers and cell and gene therapy developers around Philadelphia. Merck plans $2.9 billion in Montgomery County through 2030, and GSK plans a new biologics plant at Upper Merion with construction expected in 2027.

How often does FDA inspect drug manufacturers in Pennsylvania?

Since the Food and Drug Administration Safety and Innovation Act of 2012, FDA inspects drug manufacturing sites on a risk-based schedule rather than a fixed two-year cycle. The schedule weighs the risk of the products made, the site’s compliance history, recalls and the time since the last inspection. New facilities and new products also bring preapproval inspections, where qualification records are reviewed closely.

What state records does a Pennsylvania autoclave need in its qualification file?

An autoclave that is an unfired pressure vessel under Pennsylvania law needs its ASME data report and nameplate details, National Board registration, relief device settings, the Department of Labor and Industry certificate of operation posted near the unit and the date of its next state inspection. Those records sit in the IQ, and change control checks whether a modification needs an inspector’s involvement first.

How long does qualification of a new purified water system take?

Commissioning and the IQ and OQ usually take several weeks after mechanical completion, then performance qualification runs in three phases: two to four weeks of intensive daily sampling, two to four weeks more under routine procedures, and a year of routine monitoring to capture seasonal change. Water can often be released for use after phase 2, with phase 3 running alongside production.

How is a phase 1 water excursion investigated before qualification restarts?

The investigation looks at the system as well as the sample: the sample point and valve, the sampling technique, loop temperature and velocity records, sanitization history, recent maintenance and any new branches or dead legs. Paul Industries traces the cause, corrects the physical problem, sanitizes the loop and agrees with the quality unit how much of phase 1 must be repeated before sampling resumes.

Can Paul Industries qualify vendor-built and existing systems at a Pennsylvania plant?

Yes. Paul Industries qualifies systems supplied by equipment vendors and installed under earlier projects. Where installation records are incomplete, it walks the system down against drawings, verifies materials, welds, slopes and instruments, records what exists and resolves gaps through the quality unit’s deviation process, then executes the operational and performance testing on the system as it stands.

What does Annex 1 change for sterile plant qualification in Pennsylvania?

The revised EU GMP Annex 1, effective in August 2023, applies to Pennsylvania plants that make sterile products for European markets and shapes expectations at many others. It requires a documented contamination control strategy, and qualification tests now trace back to it: clean room classification and recovery, airflow visualization, isolator and barrier integrity, sterilization cycle performance and water system control.

How is computerized system validation handled during CQV?

Automated equipment and monitoring systems are qualified with a GAMP 5 approach scaled to risk: configuration and functional testing, alarm and interlock verification, audit trail and electronic record checks for 21 CFR Part 11, security and access control, and backup and restore. Data integrity tests confirm that records are attributable, complete and protected from change, so the system’s data can support release decisions.

Can CQV execution run around production at an operating Pennsylvania plant?

Yes. Execution is planned around production schedules, gowning requirements and shared utilities. Tests that disturb operation, such as loop sanitization, clean room recovery and power interruption checks, are grouped into planned shutdown windows, while documentation-only and nonintrusive tests run during production. Paul Industries agrees the schedule with operations and quality before the first protocol is executed.

Does a Pennsylvania building need its occupancy approval before equipment qualification?

Building approval and GMP qualification run on separate tracks. The Uniform Construction Code governs occupancy of the building, while qualification answers to the quality unit and FDA expectations. Commissioning and IQ often begin before final building approval, and the plan sets which tests depend on finished building systems, such as HVAC performance, so the two schedules stay aligned.

What should be sent to get a validation and commissioning quote in Pennsylvania?

Send the list of systems, user requirement specifications or a validation master plan if one exists, available vendor documents and factory test reports, the plant’s protocol templates if they must be used, and the target release date. Note which systems are direct-impact and whether the site supplies EU markets. Paul Industries returns a scope by system, a schedule and a price.

Qualifying new systems at a Pennsylvania plant?

Send the system list, the user requirements or validation master plan, vendor documents and the release date you are working toward. Call 201-450-8280 or request a quote.